|
|
||||||||||||||
|
|
|||||||||||||||
ORIGINAL ARTICLE |
1 Department of Pathology, Coombe Women's Hospital, Dublin 8, Ireland
2 Department of Histopathology, Trinity College, Dublin, Ireland,
3 Department of Paediatric Gastroenterology, the Royal Free Hospital, London, UK
4 Department of Medicine, The Royal Free Hospital and University College Medical School, London, UK
Correspondence to:
Professor J J O'Leary, Department of Pathology, Coombe Women's Hospital, Dublin 8, Ireland;
joleary{at}coombe.ie
Aims: A new form of inflammatory bowel disease (ileocolonic lymphonodular hyperplasia) has been described in a cohort of children with developmental disorder. This study investigates the presence of persistent measles virus in the intestinal tissue of these patients (new variant inflammatory bowel disease) and a series of controls by molecular analysis.
Methods: Formalin fixed, paraffin wax embedded and fresh frozen biopsies from the terminal ileum were examined from affected children and histological normal controls. The measles virus Fusion (F) and Haemagglutinin (H) genes were detected by TaqMan reverse transcription polymerase chain reaction (RT-PCR) and the Nucleocapsid (N) gene by RT in situ PCR. Localisation of the mRNA signal was performed using a specific follicular dendritic cell antibody.
Results: Seventy five of 91 patients with a histologically confirmed diagnosis of ileal lymphonodular hyperplasia and enterocolitis were positive for measles virus in their intestinal tissue compared with five of 70 control patients. Measles virus was identified within the follicular dendritic cells and some lymphocytes in foci of reactive follicular hyperplasia. The copy number of measles virus ranged from one to 300 000 copies/ng total RNA.
Conclusions: The data confirm an association between the presence of measles virus and gut pathology in children with developmental disorder.
Keywords: inflammatory bowel disease; measles; developmental disorder
Abbreviations: AP, alkaline phosphatase; BCIP, bromochloroindoylphosphate; DIG, digoxigenin; F, fusion; H, haemagglutinin; IL, interleukin; LNH, lymphonodular hyperplasia; MV, measles virus; N, nucleocapsid; NBT, nitrobluetetrazolium; PCR, polymerase chain reaction; RT, reverse transcription; SSC, saline sodium citrate; SSPE, subacute sclerosing panencephalitis; Th1, T helper cell type 1
This article has been cited by other articles:
![]() |
S. T. Schultz, H. S. Klonoff-Cohen, D. L. Wingard, N. A. Akshoomoff, C. A. Macera, and Ming Ji Acetaminophen (paracetamol) use, measles-mumps-rubella vaccination, and autistic disorder: The results of a parent survey Autism, May 1, 2008; 12(3): 293 - 307. [Abstract] [PDF] |
||||
![]() |
D. Elliman and H. Bedford MMR: where are we now? Arch. Dis. Child., December 1, 2007; 92(12): 1055 - 1057. [Full Text] [PDF] |
||||
![]() |
Y. D'Souza, S. Dionne, E. G Seidman, A. Bitton, and B. J Ward No evidence of persisting measles virus in the intestinal tissues of patients with inflammatory bowel disease Gut, June 1, 2007; 56(6): 886 - 888. [Full Text] [PDF] |
||||
![]() |
Y. D'Souza, E. Fombonne, and B. J. Ward No Evidence of Persisting Measles Virus in Peripheral Blood Mononuclear Cells From Children With Autism Spectrum Disorder Pediatrics, October 1, 2006; 118(4): 1664 - 1675. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Katz Has the Measles-Mumps-Rubella Vaccine Been Fully Exonerated? Pediatrics, October 1, 2006; 118(4): 1744 - 1745. [Full Text] [PDF] |
||||
![]() |
H. C. Meissner, P. M. Strebel, and W. A. Orenstein Measles Vaccines and the Potential for Worldwide Eradication of Measles Pediatrics, October 1, 2004; 114(4): 1065 - 1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Parker, B. Schwartz, J. Todd, and L. K. Pickering Thimerosal-Containing Vaccines and Autistic Spectrum Disorder: A Critical Review of Published Original Data Pediatrics, September 1, 2004; 114(3): 793 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fitzpatrick MMR: risk, choice, chance Br. Med. Bull., June 1, 2004; 69(1): 143 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
J J O'Leary Potential viral pathogenic mechanism for new variant inflammatory bowel disease Mol. Pathol., August 1, 2003; 56(4): 248 - 248. [Full Text] [PDF] |
||||
![]() |
J. F. White Intestinal Pathophysiology in Autism Experimental Biology and Medicine, June 1, 2003; 228(6): 639 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Geier and D. A. Geier Neurodevelopmental Disorders after Thimerosal-Containing Vaccines: A Brief Communication Experimental Biology and Medicine, June 1, 2003; 228(6): 660 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
MMR vaccine - how effective and how safe? DTB, April 1, 2003; 41(4): 25 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. O. Spitzer, M. E. Mullins, A. J. Wakefield, K. K. Noble, K. Miyasaka, K. M. Madsen, and E. W. Campion Measles, Mumps, and Rubella Vaccination and Autism N. Engl. J. Med., March 6, 2003; 348(10): 951 - 954. [Full Text] [PDF] |
||||
![]() |
A. J. Vyse, N. J. Gay, J. M. White, M. E. Ramsay, D. W. G. Brown, B. J. Cohen, L. M. Hesketh, P. Morgan-Capner, and E. Miller Evolution of Surveillance of Measles, Mumps, and Rubella in England and Wales: Providing the Platform for Evidence-based Vaccination Policy Epidemiol. Rev., December 1, 2002; 24(2): 125 - 136. [Full Text] [PDF] |
||||
![]() |
K. M. Madsen, A. Hviid, M. Vestergaard, D. Schendel, J. Wohlfahrt, P. Thorsen, J. Olsen, and M. Melbye A Population-Based Study of Measles, Mumps, and Rubella Vaccination and Autism N. Engl. J. Med., November 7, 2002; 347(19): 1477 - 1482. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Morris and D Aldulaimi New evidence for a viral pathogenic mechanism for new variant inflammatory bowel disease and development disorder? Mol. Pathol., April 1, 2002; 55(2): 83 - 83. [Full Text] [PDF] |
||||
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| Molecular Pathology | Journal of Clinical Pathology |